20 LATEST RESOURCES (91 INDEXED)
Supraventricular Tachycardia Caused by Amisulpride Intoxication · September 2023
Articles
Primary Care Companion for CNS Disorders
Repetitive Transcranial Magnetic Stimulation Combined with Olanzapine and Amisulpride for Treatment-Refractory Schizophrenia · July 2023
Articles
World Journal of Psychiatry
Does Drug Use Affect the Efficacy of Amisulpride, Aripiprazole and Olanzapine in Patients with Schizophrenia Spectrum Disorders? Results from a Pragmatic, Randomised Study · May 2023
Articles
General Hospital Psychiatry
Amisulpride-Induced High Elevation in Prolactin Levels · January 2023
Articles
Primary Care Companion for CNS Disorders
Optimizing Subjective Wellbeing with Amisulpride in First Episode Schizophrenia or Related Disorders · December 2022
Articles
Psychological Medicine
Case Report: Amisulpride Therapy Induced Reversible Elevation of Creatine Kinase-MB and Bradycardia in Schizophrenia · December 2022
Articles
Frontiers in Psychiatry
Amisulpride Augmentation Therapy Improves Cognitive Performance and Psychopathology in Clozapine-Resistant Treatment-Refractory Schizophrenia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial · October 2022
Articles
Military Medical Research
Amisulpride Associated Hyperprolactinemia and Gynecomastia in a Young Male Patient: A Rare Case Report and Systematic Literature Review of Drug-Induced Hyperprolactinemia · July 2022
Articles
Psychiatry Research Case Reports
When to Use Amisulpride in Adolescents: A Retrospective Chart Examination of Inpatients · May 2022
Abstracts
Journal of Clinical Psychopharmacology
Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients with First-Episode Psychoses · March 2022
Articles
Frontiers in Psychiatry
Analysis of Gut Microbiota in Patients with Exacerbated Symptoms of Schizophrenia Following Therapy with Amisulpride: A Pilot Study · March 2022
Articles
Behavioural Neurology
A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-Racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression · October 2021
Articles
Journal of Affective Disorders
Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level · September 2021
Articles
Drug Design, Development and Therapy
Efficacy of Amisulpride for Depressive Symptoms in Individuals with Mental Disorders: A Systematic Review and Meta-Analysis · June 2021
Articles
Human Psychopharmacology: Clinical and Experimental
Baseline Levels of C-Reactive Protein and Proinflammatory Cytokines Are Not Associated with Early Response to Amisulpride in Patients with First Episode Psychosis: The OPTiMiSE Cohort Study · May 2021
Articles
Schizophrenia Bulletin Open
Study on the Relationship among Dose, Concentration and Clinical Response in Chinese Schizophrenic Patients Treated with Amisulpride · May 2021
Abstracts
Asian Journal of Psychiatry
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial · April 2021
Articles
Frontiers in Pharmacology
Clinical Usefulness of Amisulpride Add-On Therapy in Schizophrenia Patients without Treatment Response to Second-Generation Antipsychotics · February 2021
Articles
Clinical Psychopharmacology and Neuroscience
Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting · January 2021
Abstracts
Anesthesia and Analgesia
Amisulpride: A New Drug for Management of Postoperative Nausea and Vomiting · January 2021
Abstracts
Annals of Pharmacotherapy